Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Price

Showing results (311-320 of 500) with videos related to

Pageof 50
Sort By:
Blood|June 23, 2009
Minor viral and host genetic polymorphisms can dramatically impact the biologic outcome of an epitope-specific CD8 T-cell responseChristof Geldmacher, Ian S Metzler, Sodsai Tovanabutra, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 16, 2012
Type I IFN induced by adenovirus serotypes 28 and 35 has multiple effects on T cell immunogenicityMatthew J Johnson, Constantinos Petrovas, Takuya Yamamoto, et al.
Organic & Biomolecular Chemistry|March 8, 2017
Comparative pharmacokinetic profile of cyclosporine (CsA) with a decapeptide and a linear analogueDavid A Price, Heather Eng, Kathleen A Farley, et al.
The Journal of Clinical Investigation|January 3, 2013
Superior T memory stem cell persistence supports long-lived T cell memoryEnrico Lugli, Maria H Dominguez, Luca Gattinoni, et al.
The Journal of Biological Chemistry|March 27, 2002
Novel CD8+ T cell antagonists based on beta 2-microglobulinMeir Glick, David A Price, Anne-Lise Vuidepot, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2022
Oropouche orthobunyavirus infection is mediated by the cellular host factor Lrp1Madeline M Schwarz, David A Price, Safder S Ganaie, et al.
European Journal of Immunology|July 29, 2024
Sepsis shapes the human γδ TCR repertoire in an age- and pathogen-dependent mannerEric Giannoni, Guillem Sanchez Sanchez, Isoline Verdebout, et al.
AIDS (London, England)|October 6, 2023
CD8 + T-cell priming is quantitatively but not qualitatively impaired in people with HIV-1 on antiretroviral therapyMariela P Cabral-Piccin, Olivia Briceño, Laura Papagno, et al.
Plos Pathogens|December 3, 2010
Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr virus infectionJohn J Miles, Anna M Bulek, David K Cole, et al.
The Journal of Clinical Investigation|October 30, 2019
SIV-specific CD8+ T cells are clonotypically distinct across lymphoid and mucosal tissuesCarly E Starke, Carol L Vinton, Kristin Ladell, et al.
Pageof 50

Showing results (311-320 of 500) with videos related to

Sort By:
Pageof 50
Blood|June 23, 2009
Minor viral and host genetic polymorphisms can dramatically impact the biologic outcome of an epitope-specific CD8 T-cell responseChristof Geldmacher, Ian S Metzler, Sodsai Tovanabutra, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 16, 2012
Type I IFN induced by adenovirus serotypes 28 and 35 has multiple effects on T cell immunogenicityMatthew J Johnson, Constantinos Petrovas, Takuya Yamamoto, et al.
Organic & Biomolecular Chemistry|March 8, 2017
Comparative pharmacokinetic profile of cyclosporine (CsA) with a decapeptide and a linear analogueDavid A Price, Heather Eng, Kathleen A Farley, et al.
The Journal of Clinical Investigation|January 3, 2013
Superior T memory stem cell persistence supports long-lived T cell memoryEnrico Lugli, Maria H Dominguez, Luca Gattinoni, et al.
The Journal of Biological Chemistry|March 27, 2002
Novel CD8+ T cell antagonists based on beta 2-microglobulinMeir Glick, David A Price, Anne-Lise Vuidepot, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2022
Oropouche orthobunyavirus infection is mediated by the cellular host factor Lrp1Madeline M Schwarz, David A Price, Safder S Ganaie, et al.
European Journal of Immunology|July 29, 2024
Sepsis shapes the human γδ TCR repertoire in an age- and pathogen-dependent mannerEric Giannoni, Guillem Sanchez Sanchez, Isoline Verdebout, et al.
AIDS (London, England)|October 6, 2023
CD8 + T-cell priming is quantitatively but not qualitatively impaired in people with HIV-1 on antiretroviral therapyMariela P Cabral-Piccin, Olivia Briceño, Laura Papagno, et al.
Plos Pathogens|December 3, 2010
Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr virus infectionJohn J Miles, Anna M Bulek, David K Cole, et al.
The Journal of Clinical Investigation|October 30, 2019
SIV-specific CD8+ T cells are clonotypically distinct across lymphoid and mucosal tissuesCarly E Starke, Carol L Vinton, Kristin Ladell, et al.
Pageof 50